---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-25-056659"
form_type: "8-K"
ticker: "GRI"
cik: "0001824293"
company_name: "GRI Bio, Inc."
filed_at: "2025-12-12T23:59:59+00:00"
generated_at: "2026-05-16T13:23:05.408645+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# GRI Bio launches $6.7M public offering of common stock and warrants

## Summary
- Offering comprises 2.6M shares, 8.1M pre-funded warrants ($0.0001/share), and 10.7M Series F warrants ($0.75/share) at $0.75 per unit.
- Net proceeds expected ~$6.7M; funds working capital, product development, and general corporate purposes.
- Closing anticipated December 12, 2025; H.C. Wainwright acts as placement agent with 7.0% cash fee plus warrants.
- Company believes proceeds plus existing cash will fund operations into Q4 2026; 60-day lockup on further equity issuance.

## SEC filing metadata
- accession: 0001628280-25-056659
- form_type: 8-K
- ticker: GRI
- cik: 0001824293
- company_name: GRI Bio, Inc.
- filed_at: 2025-12-12T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1824293/000162828025056659/0001628280-25-056659-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1824293/000162828025056659/val-20251211.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-25-056659
- JSON: https://secwatch.observer/filing/0001628280-25-056659.json
- Plain text: https://secwatch.observer/filing/0001628280-25-056659.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.